A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis

1. Cibeira, M.T.
2. Oriol, A.
3. Lahuerta, J.J.
4. Mateos, M.-V.
5. de la Rubia, J.
6. Hernández, M.T.
7. Granell, M.
8. Fernández de Larrea, C.
9. San Miguel, J.F.
10. Bladé, J.